Daily Current Affairs / DCGI approves two clinical trials of indigenous Covid vaccine Corbevax
Category : National Published on: September 04 2021
· The Drug Controller General of India- DCGI has approved two clinical trials of indigenous Covid vaccine Corbevax.
· Vaccine maker Biologicals E has received permission for Phase II and III trials on children between the ages of five and eighteen under certain conditions.
· The Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council – BIRAC have provided support to Biologicals E's COVID-19 Vaccine.
· This support will be provided from the preclinical phase to the third phase of the trial.
Important facts
About the DCGI
v DCGI: Drugs Controller General of India
v Headquarters location: New Delhi
Cabinet approves restructuring of PM SVANidhi Scheme with extension till March 2030 to benefit 1.15 crore street vendors.
Read More....Centre forms PM-led committees for Patel’s and Birsa Munda’s 150th birth anniversaries and Vajpayee’s centenary celebrations.
Read More....India and Bhutan sign MoU to enhance cooperation in agriculture, livestock, and allied sectors.
Read More....Raksha Rajya Mantri Sanjay Seth inaugurates MILMEDICON-2025, global military medicine conference, in New Delhi.
Read More....Astronomers capture first-ever direct image of baby planet WISPIT 2b orbiting star WISPIT 2 in constellation Aquila.
Read More....SEBI approves Groww IPO, paving way for $1 billion fintech listing in India.
Read More....Indian-origin banker Piyush Gupta appointed Alternate Member of Singapore’s Council of Presidential Advisers for four years.
Read More....Gangwal family trust sells ₹2,933 crore stake in IndiGo, taking 2025 divestment total beyond ₹39,500 crore.
Read More....Murugappa Group’s CG Semi launches ₹7,600 crore semiconductor pilot line in Gujarat under India Semiconductor Mission.
Read More....Former RBI Governor Urjit Patel appointed IMF Executive Director for a three-year term.
Read More....